3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
17
Multiple Myeloma
13
Lymphoma, Non-Hodgkin
13
Hodgkin Disease
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Leukemia, Lymphocytic, Chronic, B-Cell
10
Myeloproliferative Disorders
9
Melanoma
8
Recurrence
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia, Biphenotypic, Acute
7
Anemia, Refractory, with Excess of Blasts
7
Lymphoma
6
Leukemia
6
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Waldenstrom Macroglobulinemia
4
Neuroblastoma
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myelomonocytic, Juvenile
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Burkitt Lymphoma
4
Uveal Melanoma
3
Stomach Neoplasms
3
Primary Myelofibrosis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Interventions
Dexamethasone
7
Bortezomib
6
Cyclophosphamide
5
daratumumab
3
Specimen Handling
3
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
3
venetoclax
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
belantamab mafodotin
2
auricularum
2
X-Rays
2
Phantoms, Imaging
2
Magnetic Resonance Spectroscopy
2
Clinical Protocols
2
Calcium Dobesilate
2
Biopsy
2
ixazomib
1
Tissue Banks
1
Stem Cell Transplantation
1
Pharmaceutical Preparations
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
fludarabine phosphate
×
90 days
×
Clear all
No trials found.